Streetbeat News

PCLOF

PharmaCielo Ltd.

Industry

All Other Miscellaneous Crop Farming

Open

0.05

Mkt cap

6.4M

Volume

193

High

0.05

P/E Ratio

-1.57

52-wk high

0.22

Low

0.05

Div yield

N/A

52-wk low

0.04

PharmaCielo reported a significant 143% year-over-year sales growth for Q4 2024, with total revenue reaching $3.54 million. The company also saw an increase in gross profit margin and a more diverse customer base.

Portfolio Pulse from

February 28, 2025 | 1:00 pm

PharmaCielo Ltd. has announced the issuance of shares to settle certain outstanding amounts. The company is a leading cultivator and producer of cannabis extracts in Colombia.

Portfolio Pulse from

February 12, 2025 | 1:00 pm

PharmaCielo Ltd. reported significant financial progress in Q3 2024, with an 85% year-over-year sales growth, total revenue of $2.4 million, positive gross profit, improved cash flow, and increased EBITDA by $0.8 million.

Portfolio Pulse from

December 02, 2024 | 1:00 pm

PharmaCielo Ltd. announced its intention to extend the expiry date of its warrants. The company is a leading cultivator and producer of cannabis extracts in Colombia.

Portfolio Pulse from

November 05, 2024 | 5:45 pm

Colombia's new decree allows the sale of dry cannabis flower locally, benefiting companies and patients. While it seems to protect small producers, it actually favors MIPYMES based on income, allowing many companies to qualify. Regulatory hurdles like sanitary authorization may delay implementation.

Portfolio Pulse from Javier Hasse

October 24, 2024 | 5:29 pm

The Czech Republic could miss out on $242 million annually by not regulating its marijuana market, according to a study. The study suggests that a comprehensive model, including self-cultivation, cannabis clubs, and a commercial market, would yield the highest social benefits. Companies like Curaleaf, PharmaCielo, Tilray, and Canopy Growth are already expanding their presence in the Czech market, potentially benefiting from future policy changes.

Portfolio Pulse from Jelena Martinovic

September 16, 2024 | 2:00 pm

PharmaCielo Ltd. (OTC:PCLOF) reported a 390% YoY revenue increase to CA$783,680 in Q2 2024, driven by cannabis derivative sales. Net loss narrowed to CA$2.6 million from CA$3.6 million in Q2 2023. The company issued 5.98 million shares for debt settlement and reduced operating expenses. Despite positive financial trends, PCLOF shares were down 4.78% to $0.0857.

Portfolio Pulse from Patricio Liddle

August 16, 2024 | 2:47 pm

The article discusses the potential for cannabis legalization in Venezuela amid political turmoil and election fraud allegations. It highlights the successes of Colombia's cannabis industry and mentions companies like Clever Leaves Holdings Inc, Khiron Life Sciences Corp, and PharmaCielo Ltd as examples of successful cannabis businesses in Colombia.

Portfolio Pulse from Patricio Liddle

July 31, 2024 | 1:02 pm

The Czech Republic is considering a fully legal commercial adult-use cannabis market under its 'Cannabis Management Act,' which includes provisions for personal cultivation, licensing, and a regulated market. Companies like Curaleaf Holdings, PharmaCielo, Tilray Brands, and Canopy Growth are already positioning themselves in anticipation of these regulatory changes.

Portfolio Pulse from Jelena Martinovic

July 15, 2024 | 2:20 pm

PharmaCielo Ltd. (TSXV:PCLO, OTC:PCLOF) reported a 31% year-over-year reduction in net loss for Q1 2024, driven by significant cost-cutting measures. The company also announced the revocation of a cease trade order by the Ontario Securities Commission and a downgrade in its TSX Venture Exchange tier classification.

Portfolio Pulse from Jelena Martinovic

July 05, 2024 | 3:02 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.